BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial
- DOI
- 10.1038/s41591-025-04170-z
- Published
- 2026-01-09
- Container
- Nature Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-025-04170-z,
title = {BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial},
author = {Renee R. Fedak and Rachel N. Ruggerie and Yufei Shan and Elizabeth J. Curvino and Juliana F. de Sousa and Shaji Daniel and Minhtran Ngo-Casi and Hafsa Kamboh and Tuan Vu and Hacer Durmuş and Tahseen Mozaffar and James F. Howard and Emily P. English and Albina Benson and Matthew T. Duvernay and Michael S. Singer and Murat V. Kalayoglu and Carsten Brunn and Aaron Bodansky and Mark S. Anderson and Joseph L. DeRisi and Samantha T. Garcia and David J. L. Yu and Kelsey C. Zorn and Metin Kurtoglu and Miloš D. Miljković and C. Andrew Stewart and Christopher M. Jewell and Unknown and Juliana F. de Sousa and Charito Buensuceso and Lisa H. Tostanoski and Yi Zhang and Heng Xu and Chad A. Pope and Dina Schneider and Adam English and Atanas Filev and Jennifer Biaksangi and George Small and Michael Rivner and Michael A. Badruddoja and Bennett Myers and Sheetal Shroff and Adam Slanksy and Kelly Holley and Gregory Sahagian and Tara Quesnell and Marc H. Feinberg and Gabrielle DeMaria and Mithila Vullaganti and Carolina Barnett-Tapia and Meg Mendoza and Mona Irannejad and Zaeem Siddiqi and Ali A. Habib and Thomas Ragole and Mamatha Pasnoor and Rebecca E. Traub and Manisha Chopra and Natalie S. Grover and Yara A. Park and Matthew Karafin and Amy Trunnell and Catherine Cheng and Chafic Karam and Darnell Davis and Jessica Shaw and Naraly Requena and Amanda Peltier and Kelly Gwathmey},
year = {2026},
journal = {Nature Medicine},
doi = {10.1038/s41591-025-04170-z},
url = {https://doi.org/10.1038/s41591-025-04170-z}
}RIS
TY - JOUR TI - BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial AU - Renee R. Fedak AU - Rachel N. Ruggerie AU - Yufei Shan AU - Elizabeth J. Curvino AU - Juliana F. de Sousa AU - Shaji Daniel AU - Minhtran Ngo-Casi AU - Hafsa Kamboh AU - Tuan Vu AU - Hacer Durmuş AU - Tahseen Mozaffar AU - James F. Howard AU - Emily P. English AU - Albina Benson AU - Matthew T. Duvernay AU - Michael S. Singer AU - Murat V. Kalayoglu AU - Carsten Brunn AU - Aaron Bodansky AU - Mark S. Anderson AU - Joseph L. DeRisi AU - Samantha T. Garcia AU - David J. L. Yu AU - Kelsey C. Zorn AU - Metin Kurtoglu AU - Miloš D. Miljković AU - C. Andrew Stewart AU - Christopher M. Jewell AU - Unknown AU - Juliana F. de Sousa AU - Charito Buensuceso AU - Lisa H. Tostanoski AU - Yi Zhang AU - Heng Xu AU - Chad A. Pope AU - Dina Schneider AU - Adam English AU - Atanas Filev AU - Jennifer Biaksangi AU - George Small AU - Michael Rivner AU - Michael A. Badruddoja AU - Bennett Myers AU - Sheetal Shroff AU - Adam Slanksy AU - Kelly Holley AU - Gregory Sahagian AU - Tara Quesnell AU - Marc H. Feinberg AU - Gabrielle DeMaria AU - Mithila Vullaganti AU - Carolina Barnett-Tapia AU - Meg Mendoza AU - Mona Irannejad AU - Zaeem Siddiqi AU - Ali A. Habib AU - Thomas Ragole AU - Mamatha Pasnoor AU - Rebecca E. Traub AU - Manisha Chopra AU - Natalie S. Grover AU - Yara A. Park AU - Matthew Karafin AU - Amy Trunnell AU - Catherine Cheng AU - Chafic Karam AU - Darnell Davis AU - Jessica Shaw AU - Naraly Requena AU - Amanda Peltier AU - Kelly Gwathmey PY - 2026 JO - Nature Medicine DO - 10.1038/s41591-025-04170-z UR - https://doi.org/10.1038/s41591-025-04170-z ER -
APA
Fedak, R. R., Ruggerie, R. N., Shan, Y., Curvino, E. J., Sousa, J. F. D., Daniel, S., Ngo-Casi, M., Kamboh, H., Vu, T., Durmuş, H., Mozaffar, T., Howard, J. F., English, E. P., Benson, A., Duvernay, M. T., Singer, M. S., Kalayoglu, M. V., Brunn, C., Bodansky, A., Anderson, M. S., DeRisi, J. L., Garcia, S. T., Yu, D. J. L., Zorn, K. C., Kurtoglu, M., Miljković, M. D., Stewart, C. A., Jewell, C. M., Unknown, Sousa, J. F. D., Buensuceso, C., Tostanoski, L. H., Zhang, Y., Xu, H., Pope, C. A., Schneider, D., English, A., Filev, A., Biaksangi, J., Small, G., Rivner, M., Badruddoja, M. A., Myers, B., Shroff, S., Slanksy, A., Holley, K., Sahagian, G., Quesnell, T., Feinberg, M. H., DeMaria, G., Vullaganti, M., Barnett-Tapia, C., Mendoza, M., Irannejad, M., Siddiqi, Z., Habib, A. A., Ragole, T., Pasnoor, M., Traub, R. E., Chopra, M., Grover, N. S., Park, Y. A., Karafin, M., Trunnell, A., Cheng, C., Karam, C., Davis, D., Shaw, J., Requena, N., Peltier, A., & Gwathmey, K. (2026). BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial. Nature Medicine. https://doi.org/10.1038/s41591-025-04170-z
Source records
- crossref · retrieved 2026-09-26T23:08:56.637Z